Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
In today’s evolving marketplace, pharma advertisers need a TV data strategy.
We talked to buy and sell side leaders in DTC. This report helps break down the space for marketers and provides a diagnosis for success when it comes to:
What the evolution of streaming means for pharma marketers
How to balance patient centricity with consumer privacy
Asking the right questions of DTC measurement
Selecting trusted partners for navigating the new world of video